Fabrication of chitosan–polyacrylic acid complexes as polymeric osmogents for swellable micro/nanoporous osmotic pumps

References

• Malaterre V, Ogorka J, Loggia N, Gurny R. (2009). Oral osmotically driven systems: 30 years of development and clinical use. Eur J Pharm Biopharm, 73:311–323.
   PubMed Web of Science ®Google Scholar
• Theeuwes F. (1975). Elementary osmotic pump. J Pharm Sci, 64:1987–1991.
   PubMed Web of Science ®Google Scholar
• Theeuwes F, Swanson D, Wong P, Bonsen P, Place V, Heimlich K et al. (1983). Elementary osmotic pump for indomethacin. J Pharm Sci, 72:253–258.
   PubMed Web of Science ®Google Scholar
• Sinchaipanid N, Pongwai S, Limsuwan P, Mitrevej A. (2003). Design of salbutamol EOP tablets from pharmacokinetics parameters. Pharm Dev Technol, 8:135–142.
   PubMed Web of Science ®Google Scholar
• Shokri J, Ahmadi P, Rashidi P, Shahsavari M, Rajabi-Siahboomi A, Nokhodchi A. (2008). Swellable elementary osmotic pump (SEOP): an effective device for delivery of poorly water-soluble drugs. Eur J Pharm Biopharm, 68:289–297.
   PubMed Web of Science ®Google Scholar
• Swanson DR, Barclay BL, Wong PS, Theeuwes F. (1987). Nifedipine gastrointestinal therapeutic system. Am J Med, 83:3–9.
   PubMedGoogle Scholar
• Liu L, Ku J, Khang G, Lee B, Rhee JM, Lee HB. (2000). Nifedipine controlled delivery by sandwiched osmotic tablet system. J Control Release, 68:145–156.
   PubMed Web of Science ®Google Scholar
• Malaterre V, Ogorka J, Loggia N, Gurny R. (2009). Approach to design push–pull osmotic pumps. Int J Pharm, 376:56–62.
   PubMed Web of Science ®Google Scholar
• Zentner GM, McClelland GA, Sutton SC. (1991). Controlled porosity solubility- and resin-modulated osmotic drug delivery systems for release of diltiazem hydrochloride. J Control Release, 16:237–244.
   Web of Science ®Google Scholar
• Zentner GM, Rork GS, Himmelstein KJ. (1985). The controlled porosity osmotic pump. J Control Release, 1:269–282.
   Google Scholar
• Tuntikulwattana S, Mitrevej A, Kerdcharoen T, Williams DB, Sinchaipanid N. (2010). Development and optimization of micro/nanoporous osmotic pump tablets. AAPS Pharmscitech, 11:924–935.
   PubMed Web of Science ®Google Scholar
• Herbig SM, Cardinal JR, Korsmeyer RW, Smith KL. (1995). Asymmetric-membrane tablet coatings for osmotic drug delivery. J Control Release, 35:127–136.
   Web of Science ®Google Scholar
• Thombre AG, Cardinal JR, DeNoto AR, Herbig SM, Smith KL. (1999). Asymmetric membrane capsules for osmotic drug delivery. I. Development of a manufacturing process. J Control Release, 57:55–64.
   PubMed Web of Science ®Google Scholar
• Thombre AG, Cardinal JR, DeNoto AR, Gibbes DC. (1999). Asymmetric membrane capsules for osmotic drug delivery II. In vitro and in vivo drug release performance. J Control Release, 57:65–73.
   PubMed Web of Science ®Google Scholar
• Thombre AG, Appel LE, Chidlaw MB, Daugherity PD, Dumont F, Evans LA et al. (2004). Osmotic drug delivery using swellable-core technology. J Control Release, 94:75–89.
   PubMed Web of Science ®Google Scholar
• Liu L, Che B. (2006). Preparation of monolithic osmotic pump system by coating the indented core tablet. Eur J Pharm Biopharm, 64:180–184.
   PubMed Web of Science ®Google Scholar
• Okimoto K, Tokunaga Y, Ibuki R, Irie T, Uekama K, Rajewski RA et al. (2004). Applicability of (SBE)7m-beta-CD in controlled-porosity osmotic pump tablets (OPTs). Int J Pharm, 286:81–88.
   PubMed Web of Science ®Google Scholar
• Verma RK, Krishna DM, Garg S. (2002). Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Control Release, 79:7–27.
   PubMed Web of Science ®Google Scholar
• Liu H, Yang XG, Nie SF, Wei LL, Zhou LL, Liu H et al. (2007). Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation. Int J Pharm, 332:115–124.
   PubMed Web of Science ®Google Scholar
• Prabakaran D, Singh P, Kanaujia P, Jaganathan KS, Rawat A, Vyas SP. (2004). Modified push–pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization. Int J Pharm, 284:95–108.
   PubMed Web of Science ®Google Scholar
• Lee JW, Kim SY, Kim SS, Lee YM, Lee KH, Kim SJ. (1999). Synthesis and characteristics of interpenetrating polymer network hydrogel composed of chitosan and poly(acrylic acid). J Appl Polym Sci, 73:113–120.
   Web of Science ®Google Scholar
• Bae YH, Kim SW. (1993). Hydrogel delivery systems based on polymer blends, block co-polymers or interpenetrating networks. Adv Drug Deliver Rev, 11:109–135.
   Web of Science ®Google Scholar
• Wang H, Li W, Lu Y, Wang Z. (1997). Studies on chitosan and poly(acrylic acid) interpolymer complex. I. Preparation, structure, pH-sensitivity, and salt sensitivity of complex-forming poly(acrylic acid):chitosan semi-interpenetrating polymer network. J Appl Polym Sci, 65:1445–1450.
   Web of Science ®Google Scholar
• Wang H, Li W, Lu Y, Wang Z, Zhong W. (1996). Studies on chitosan and poly(acrylic acid) interpolymer complex. II. Solution behaviors of the mixture of water-soluble chitosan and poly(acrylic acid). J Appl Polym Sci, 61:2221–2224.
   Web of Science ®Google Scholar
• Nge TT, Yamaguchi M, Hori N, Takemura A, Ono H. (2002). Synthesis and characterization of chitosan/poly(acrylic acid) polyelectrolyte complex. J Appl Polym Sci, 83:1025–1035.
   Web of Science ®Google Scholar
• Ahn JS, Choi HK, Cho CS. (2001). A novel mucoadhesive polymer prepared by template polymerization of acrylic acid in the presence of chitosan. Biomaterials, 22:923–928.
   PubMed Web of Science ®Google Scholar
• Ahn JS, Choi HK, Chun MK, Ryu JM, Jung JH, Kim YU et al. (2002). Release of triamcinolone acetonide from mucoadhesive polymer composed of chitosan and poly(acrylic acid) in vitro. Biomaterials, 23:1411–1416.
   PubMed Web of Science ®Google Scholar
• De la Torre PM, Torrado S, Torrado S. (2003). Interpolymer complexes of poly(acrylic acid) and chitosan: influence of the ionic hydrogel-forming medium. Biomaterials, 24:1459–1468.
   PubMed Web of Science ®Google Scholar
• De la Torre PM, Enobakhare Y, Torrado G, Torrado S. (2003). Release of amoxicillin from polyionic complexes of chitosan and poly(acrylic acid). Study of polymer/polymer and polymer/drug interactions within the network structure. Biomaterials, 24:1499–1506.
   PubMed Web of Science ®Google Scholar
• Torrado S, Prada P, de la Torre PM, Torrado S. (2004). Chitosan–poly(acrylic) acid polyionic complex: in vivo study to demonstrate prolonged gastric retention. Biomaterials, 25:917–923.
   PubMed Web of Science ®Google Scholar
• Rossi S, Sandri G, Ferrari F, Bonferoni MC, Caramella C. (2003). Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid. Pharm Dev Technol, 8:199–208.
   PubMed Web of Science ®Google Scholar
• Hu Y, Jiang X, Ding Y, Ge H, Yuan Y, Yang C. (2002). Synthesis and characterization of chitosan–poly(acrylic acid) nanoparticles. Biomaterials, 23:3193–3201.
   PubMed Web of Science ®Google Scholar
• De la Torre PM, Torrado G, Torrado S. (2004). Poly(acrylic acid) chitosan interpolymer complexes for stomach controlled antibiotic delivery. J Biomed Mater Res, 72B:191–197.
   Web of Science ®Google Scholar
• Illum L. (1998). Chitosan and its use as a pharmaceutical excipient. Pharm Res, 15:1326–1331.
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Service Food and Drug Administration Center for Drug Evaluation and Research (CDER). (1997). Guidance for Industry: Modified Release Solid Oral Dosage Forms: SUPAC-MR: Chemistry, Manufacturing and Controls, In vitro Dissolution Testing and In vivo Bioequivalence Documentation (September 1997). Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070640.pdf. Accessed on July 9, 2010.
   Google Scholar
• Moharram MA, Balloomal LS, El-Gendy HM. (1996). Infrared study of the complexation of poly(acrylic acid) with poly(acrylamide). J Appl Polym Sci, 59:987–990.
   Web of Science ®Google Scholar
• Wu Y, Guo J, Yang W, Wang C, Fu S. (2006). Preparation and characterization of chitosan–poly(acrylic acid) polymer magnetic microspheres. Polymer, 47:5287–5294.
   Web of Science ®Google Scholar
• Risbud MV, Hardikar AA, Bhat SV, Bhonde RR. (2000). pH-sensitive freeze-dried chitosan–polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery. J Control Release, 68:23–30.
   PubMed Web of Science ®Google Scholar
• Shin HS, Kim SY, Lee YM. (1997). Indomethacin release behaviors from pH and thermoresponsive poly(vinyl alcohol) and poly(acrylic acid) IPN hydrogels for site-specific drug delivery. J Appl Polym Sci, 65:685–693.
   Web of Science ®Google Scholar
• Takka S. (2003). Propranolol hydrochloride–anionic polymer binding interaction. Farmaco, 58:1051–1056.
   PubMedGoogle Scholar
• Siemoneit U, Schmitt C, Alvarez-Lorenzo C, Luzardo A, Otero-Espinar F, Concheiro A et al. (2006). Acrylic/cyclodextrin hydrogels with enhanced drug loading and sustained release capability. Int J Pharm, 312:66–74.
   PubMed Web of Science ®Google Scholar
• Rigo MV, Allemandi DA, Manzo RH. (2006). Swellable drug–polyelectrolyte matrices (SDPM) of alginic acid characterization and delivery properties. Int J Pharm, 322:36–43.
   PubMedGoogle Scholar
• Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13: 123–133.
   PubMed Web of Science ®Google Scholar